
The Cooper Companies COO
$ 70.06
0.98%
Quarterly report 2025-Q4
added 03-06-2026
Country |
|
IPO year |
- |
Industry |
Medical instruments |
Stock Exchange |
NYSESPB |
Shares |
199 M |
Market Cap[1] |
$ 13.9 B |
EBITDA (LTM) |
$ 1.04 B |
P/E (LTM) |
32.73 |
P/S (LTM) |
3.41 |
EPS (LTM) |
2.12 |
Other stocks of industry "Medical instruments"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
Ekso Bionics Holdings
EKSO
|
$ 10.81 | 4.34 % | $ 26.2 M | Nasdaq Capital Market | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Haemonetics Corporation
HAE
|
$ 61.62 | 2.51 % | $ 3.1 B | NYSE,SPB | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
iRhythm Technologies
IRTC
|
$ 125.32 | 2.21 % | $ 4.01 B | Nasdaq Global Select Market,SPB | ||
|
Alcon
ALC
|
$ 81.32 | 2.23 % | $ 40.4 B | NYSE | ||
|
Repro Med Systems
KRMD
|
$ 4.33 | 3.59 % | $ 200 M | Nasdaq Capital Market | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Masimo Corporation
MASI
|
$ 178.39 | 0.06 % | $ 9.51 B | Nasdaq Global Select Market,SPB | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
Harvard Bioscience
HBIO
|
$ 6.13 | 3.72 % | $ 272 M | Nasdaq Global Market | ||
|
Merit Medical Systems
MMSI
|
$ 70.93 | 1.18 % | $ 4.2 B | Nasdaq Global Select Market,SPB | ||
|
electroCore
ECOR
|
$ 6.5 | -2.69 % | $ 55.1 K | Nasdaq Global Select Market | ||
|
Milestone Scientific
MLSS
|
$ 0.28 | 6.02 % | $ 23 M | NYSE American | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
Glaukos Corporation
GKOS
|
$ 124.79 | 2.61 % | $ 6.04 B | NYSE,SPB | ||
|
Microbot Medical
MBOT
|
$ 2.34 | -2.09 % | $ 107 M | Nasdaq Global Select Market | ||
|
ICU Medical
ICUI
|
$ 129.96 | 3.11 % | $ 3.2 B | Nasdaq Global Select Market,SPB | ||
|
InfuSystem Holdings
INFU
|
$ 10.58 | 3.42 % | $ 218 M | NYSE American | ||
|
STERIS plc
STE
|
$ 225.79 | 2.65 % | $ 22.3 B | NYSE,SPB | ||
|
Retractable Technologies
RVP
|
$ 0.67 | -2.9 % | $ 20.1 M | NYSE American | ||
|
Teleflex Incorporated
TFX
|
$ 131.58 | 1.04 % | $ 5.87 B | NYSE,SPB | ||
|
Envista Holdings Corporation
NVST
|
$ 27.84 | 3.34 % | $ 4.68 B | NYSE | ||
|
Utah Medical Products
UTMD
|
$ 70.65 | 1.58 % | $ 229 M | Nasdaq Global Select Market | ||
|
Intuitive Surgical
ISRG
|
$ 469.21 | 2.43 % | $ 167 B | Nasdaq Global Select Market,SPB | ||
|
Pro-Dex
PDEX
|
$ 53.4 | 1.52 % | $ 176 M | Nasdaq Global Select Market | ||
|
DENTSPLY SIRONA
XRAY
|
$ 12.51 | 3.47 % | $ 2.49 B | Nasdaq Global Select Market,SPB | ||
|
LeMaitre Vascular
LMAT
|
$ 114.36 | 2.43 % | $ 2.59 B | Nasdaq Global Market,SPB | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | ||
|
BioLife Solutions
BLFS
|
$ 21.5 | 3.12 % | $ 990 M | Nasdaq Global Select Market | ||
|
Baxter International
BAX
|
$ 18.71 | 3.14 % | $ 9.6 B | NYSE,SPB | ||
|
ResMed
RMD
|
$ 228.12 | 1.51 % | $ 33.3 B | NYSE,SPB | ||
|
AtriCure
ATRC
|
$ 29.72 | 2.91 % | $ 1.42 B | Nasdaq Global Market,SPB | ||
|
Pulse Biosciences
PLSE
|
$ 23.4 | 14.09 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
Stereotaxis
STXS
|
$ 2.03 | 1.0 % | $ 185 M | NYSE American | ||
|
STAAR Surgical Company
STAA
|
$ 25.08 | 1.87 % | $ 1.24 B | Nasdaq Global Market,SPB | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
West Pharmaceutical Services
WST
|
$ 273.73 | 1.45 % | $ 19.8 B | NYSE,SPB | ||
|
AngioDynamics
ANGO
|
$ 10.86 | 3.82 % | $ 444 M | Nasdaq Global Select Market | ||
|
Becton, Dickinson and Company
BDX
|
$ 158.54 | 2.4 % | $ 45.6 B | NYSE,SPB | ||
|
Nephros
NEPH
|
$ 2.95 | - | $ 30.6 M | Nasdaq Global Select Market | ||
|
OraSure Technologies
OSUR
|
$ 3.16 | -1.56 % | $ 232 M | Nasdaq Global Select Market,SPB | ||
|
Repligen Corporation
RGEN
|
$ 131.21 | 3.24 % | $ 7.31 M | Nasdaq Global Select Market,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.